Hydroxyethyl starch for perioperative goal-directed fluid therapy in 2020: a narrative review
Article 2020 en
Authors
AJ
Alexandre Joosten
SC
Sean Coeckelenbergh
BA
Brenton Alexander
Abstract
1 min read
The type and volume of fluid used for perioperative management need to be individualized according to the patient's hemodynamic status and clinical condition. The amount of fluid given should be guided by well-defined physiologic targets. Compliance with a predefined hemodynamic protocol may be optimized by using a computerized system. The type of fluid should also be individualized, as should any drug therapy, with careful consideration of timing and dose. It is our perspective that HES solutions remain a valid option for fluid therapy in the perioperative context because of their effects on blood volume and their reasonable benefit/risk profile.
Jean Louis Vincent, Paolo Pelosi, Rupert M. Pearse, Didier Payen, Azriel Perel, Andreas Hoeft, Stefano Romagnoli, V. Marco Ranieri, Carole Ichaï, Patrice Forget, Giorgio Della Rocca, Andrew Rhodes
Alexandre Joosten, Shalini Raj Lawrence, Alexandra Colesnicenco, Sean Coeckelenbergh, Jean Louis Vincent, Philippe Van der Linden, Maxime Cannesson, Joseph Rinehart
Discussion(0)
No comments yet. Be the first to comment.